The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?
NCT01995760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2014-09-04
Summary
The purpose of this study is to evaluate which is the most appropriate parameter correlates with clinical effectiveness of vancomycin: trough drug level or AUC/MIC.
Conditions
- Methicillin-resistant Staphylococcus Aureus Septicemia
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Li-Jiuan Shen · National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Vancomycin Dosage Strategy Based on a Trough Concentration Model
NCT04088305 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
NCT04337840 ·Status: UNKNOWN
-
A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021
NCT05762094 ·Status: UNKNOWN
-
Vancomycin Dosage Adjustment for MRSA Infections
NCT03412500 ·Status: UNKNOWN ·Phase: PHASE4
-
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
NCT04793152 ·Status: RECRUITING ·Phase: NA
-
Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients
NCT01157533 ·Status: TERMINATED ·Phase: NA
-
Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia
NCT01975662 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model
NCT06161870 ·Status: RECRUITING ·Phase: PHASE4
-
Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
NCT00695903 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of Vancomycin Loading Therapy
NCT01623817 ·Status: COMPLETED ·Phase: NA
-
Model-informed Precision Dosing of Vancomycin in Adults
NCT05535075 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
NCT05094154 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children
NCT02694458 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
NCT01786161 ·Status: TERMINATED ·Phase: PHASE4
-
Beta-lactam Therapeutic Drug Monitoring in Singapore
NCT04450680 ·Status: UNKNOWN
-
Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin
NCT01720940 ·Status: UNKNOWN ·Phase: NA
-
Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project
NCT02945241 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
NCT02596984 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT05942157 ·Status: RECRUITING ·Phase: NA
-
Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation
NCT01925066 ·Status: COMPLETED ·Phase: PHASE2
-
Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
NCT00427076 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Vancomycin in Adults Receiving ECMO
NCT00281281 ·Status: COMPLETED ·Phase: PHASE4
-
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
NCT04434300 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry
NCT02896218 ·Status: UNKNOWN